Skip to main content
VYNE Therapeutics Inc. logo

VYNE Therapeutics Inc. — Investor Relations & Filings

Ticker · VYNE ISIN · US92941V1008 US Manufacturing
Open in API
Filings indexed 608 across all filing types
Latest filing 2021-09-03 Director's Dealing
Country US United States of America
Listing US VYNE

About VYNE Therapeutics Inc.

https://vynetherapeutics.com/

VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company's primary objective is to address unmet medical needs by advancing a pipeline of novel drug candidates. VYNE's approach centers on innovating beyond traditional assumptions to find improved solutions for patients with complex inflammatory and immunological diseases.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2021-09-03 English
FORM 4 SUBMISSION
Director's Dealing
2021-09-03 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. The content focuses on the approval and grant of restricted stock units and stock options to employees and management, including specific details about the awards and vesting schedules. This indicates it is an announcement related to compensatory arrangements for officers and employees. The key section is Item 5.02, which pertains to departure or appointment of directors or officers and compensatory arrangements. This fits the category of Board/Management Information (MANG), as it involves management compensation and changes related to officers. The document is not a full annual or quarterly report, nor an earnings release or proxy statement. It is a regulatory filing but specifically about management compensation and appointments, so MANG is the most appropriate classification.
2021-09-03 English
FORM 4 SUBMISSION
Director's Dealing
2021-08-26 English
SC 13G/A
Major Shareholding Notification
2021-08-25 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2021-08-19 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.